IGF1 and metabolic dysfunction-associated steatotic liver disease: In addition, miR-190b is upregulated in NAFLD and regulates lipid metabolism and insulin sensitivity by targeting insulin-like growth factor 1 (IGF-1) and thrombospondin motifs 9 (ADAMTS9) [69].